Eastern District of New York Excludes Entire Testimony from Plaintiff”s Purported Regulatory and Warnings Expert
- Pharmaceutical & Medical Device
- May 3, 2011
For over three decades, Julie Blum has defended corporate clients in complex mass tort products liability litigation in state and federal proceedings. She plays an integral role on the firm’s trial teams with her ability to cut through the chaff and oversee and manage large-scale litigation involving a wide range of pharmaceutical products and compounds. Always on the ball, Julie is often considered a “team manager” as she skillfully orchestrates the firm’s litigation teams by assembling the manpower, addressing the client’s needs, and triaging the work as necessary.
Julie is experienced in mass tort claims, including serial litigation, multidistrict litigation, and class action litigation, and also has experience in commercial contract litigation. She has successfully managed pre-trial fact discovery in products liability and mass tort litigation for more than thirty years. Managing many aspects of a case, Julie most enjoys putting together the pieces of the puzzle to tell a compelling story and the intense concentration that requires.
Having spoken on defense strategies before national pharmaceutical conference attendees, Julie has also been a contributor to the Products Liability Law & Strategy Reporter, published by Law Journal Newsletters. She joined the firm in 1990 following a clerkship with the Honorable Mildred M. Edwards of the District of Columbia Superior Court.
When not practicing law, Julie is a fierce leader and passionate volunteer of the Tuberous Sclerosis Complex Alliance, a national non-profit, where she serves on the Board of Directors and on the Board’s Government Relations and Governance Committees. Julie is a past co-chair of the Government Relations Committee. Additionally, she also is a past member of the Board of Directors of the Tuberous Sclerosis Complex Alliance Endowment Fund.